Non-specific irreversible 89 Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89 Zr-immuno-PET.
Jessica E WijngaardenYvonne W S JauwGerben J C ZwezerijnenBerlinda J de Wit-van der VeenDaniëlle J VugtsJosée M ZijlstraGuus A M S van DongenRonald BoellaardC Willemien Menke-van der Houven van OordtMarc C HuismanPublished in: EJNMMI research (2024)
Zr-immuno-PET, even if the target is absent, a tumour-to-plasma ratio always increases over time.